Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Strong therapies, JB to lift Torrent Pharma
A strong performance in the July–September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals. Several brokerages have…
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
These certificates cover all activities conducted in the site's Helix building, including its supporting warehouse and laboratory areas. The certificates were granted following the site's submission of an MHRA GMP compliance report and the…
Unethical Practices of Pharma Firms: People Should Have Proper Remedy, Says SC
New Delhi: The Supreme Court on Tuesday said procedures under the uniform code for pharmaceutical marketing should be so strong that any consumer who was cheated should have access and proper remedy against unethical practices. A bench of Justice…
Switzerland releases further CHF50 million Sudan aid
The situation for the civilian population of Sudan and the region has worsened following the capture of the town of El-Fasher by the paramilitary Rapid Support Forces, in the conflict that has pitted them against Sudan's regular armed forces since…
Switzerland misses transalpine freight targets
The access routes are slowing down. The Federal Council is therefore lobbying neighbouring countries for rapid modernisation. The modal shift target of 650,000 lorry journeys set out in the Alpine Initiative adopted in 1994 was also exceeded in…
Swiss army knife maker relieved by US tariff cut
This creates a more manageable framework for exports, Carl Elsener told the AWP news agency on Wednesday. Thanks to this reduction, “the financial sacrifice” for deliveries to the US will be less, he said. At the same time, the…
Wedbush Reiterates Outperform Rating for Ascendis Pharma A/S (NASDAQ:ASND)
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock had its 'outperform' rating reiterated by investment analysts at Wedbush in a report issued on Tuesday, Benzinga reports. They presently have a $220.00 target price on the biotechnology…
India's drug industry saved the world once. Can it do it again?
The phone rang just before midnight. It was early February in 2001 in Mumbai, and Yusuf Hamied, a seasoned chemist at the Indian multinational pharma company Cipla, was at a dinner party. He picked up the phone anyway. A New York Times reporter was…
Ascendis Pharma A/S (NASDAQ:ASND) Now Covered by Analysts at Wolfe Research
Analysts at Wolfe Research initiated coverage on shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a 'peer perform' rating and a $255.00 price target on the…
Dorsey Wright & Associates Purchases New Shares in Ascendis Pharma A/S $ASND
Dorsey Wright & Associates purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 9,272 shares of the…
Vise Technologies Inc. Makes New $222,000 Investment in Ascendis Pharma A/S $ASND
Vise Technologies Inc. purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased…
Artisan Partners Limited Partnership Decreases Position in Ascendis Pharma A/S $ASND
Artisan Partners Limited Partnership trimmed its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 6.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
ARS Investment Partners LLC Sells 55,234 Shares of Ascendis Pharma A/S $ASND
ARS Investment Partners LLC lessened its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 20.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 209,930 shares of the…
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: - Amgen (NASDAQ:AMGN)
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%. Investors remain in risk-off mode toward 2025's high-flying names…
Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock - Olema Pharmaceuticals (NASDAQ:OLMA)
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:) soared Tuesday in reaction to Roche Holdings AG ‘s (OTC:) phase 3 results from the lidERA Breast Cancer study of giredestrant in early-stage breast cancer. 'Pharma Bro” and notorious…
Receive a Daily briefing on Pharma Industry News
Get Started